Phenobarbital and some anesthesia implications

Paediatric Anaesthesia

Volumn 21, Issue 10, 2011, Pages 995-997

  Sumpter, Anita ^a   Anderson, Brian J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

HALOTHANE; KETAMINE; PARACETAMOL; PHENOBARBITAL;

CHILD; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG USE; EPILEPSY; HALOTHANE LIVER INJURY; HUMAN; HYPERBILIRUBINEMIA; LIVER TOXICITY; PRIORITY JOURNAL; REVIEW;

ANTICONVULSANTS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MAGNETIC RESONANCE IMAGING; MALE; PHENOBARBITAL;

EID: 80052425635     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2011.03662.x     Document Type: Review

References (31)

1. Eker HE, Cok OY, Aribogan A, et al. Children on phenobarbital monotherapy requires more sedatives during MRI. Pediatr Anesth 2011; 21: 998-1002.
2. Battino D, Estienne M, Avanzini G,. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: phenobarbital, primidone, valproic acid, ethosuximide and mesuximide. Clin Pharmacokinet 1995; 29: 257-286.
3. Conney AH, Davison C, Gastel R, et al. Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs. J Pharmacol Exp Ther 1960; 130: 1-8.
4. Perucca E,. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol 2006; 61: 246-255. (Pubitemid 43382623)
5. Strolin Benedetti M, Ruty B, Baltes E,. Induction of endogenous pathways by antiepileptics and clinical implications. Fundam Clin Pharmacol 2005; 19: 511-529.
6. Corcos L, Lagadic-Gossmann D,. Gene induction by phenobarbital: an update on an old question that receives key novel answers. Pharmacol Toxicol 2001; 89: 113-122. (Pubitemid 32905240)
7. Hollmann S, Touster O,. Alterations in tissue levels of uridine diphosphate glucose dehydrogenase, uridine diphosphate glucuronic acid pyrophosphatase and glucuronyl transferase induced by substances influencing the production of ascorbic acid. Biochim Biophys Acta 1962; 62: 338-352.
8. Inscoe JK, Axelrod J,. Some factors affecting glucuronide formation in vitro. J Pharmacol Exp Ther 1960; 129: 128-131.
9. Sugatani J, Yamakawa K, Tonda E, et al. The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics. Biochem Pharmacol 2004; 67: 989-1000. (Pubitemid 38201644)
10. Sugatani J, Kojima H, Ueda A, et al. The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 2001; 33: 1232-1238. (Pubitemid 32378224)
11. Valaes T, Karaklis A, Stravrakakis D, et al. Incidence and mechanism of neonatal jaundice related to glucose-6-phosphate dehydrogenase deficiency. Pediatr Res 1969; 3: 448-458.
12. Srinivasan G, Seeler RA, Tiruvury A, et al. Maternal anticonvulsant therapy and hemorrhagic disease of the newborn. Obstet Gynecol 1982; 59: 250-252. (Pubitemid 12163087)
13. Wallin A, Boreus LO,. Phenobarbital prophylaxis for hyperbilirubinemia in preterm infants. A controlled study of bilirubin disappearance and infant behavior. Acta Paediatr Scand 1984; 73: 488-497. (Pubitemid 14084693)
14. Blackburn MG, Orzalesi MM, Pigram P,. The combined effect of phototherapy and phenobarbital on serum bilirubin levels of premature infants. Pediatrics 1972; 49: 110-112.
15. Benet LZ, Hoener BA,. Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther 2002; 71: 115-121. (Pubitemid 34271114)
16. Sanderson JP, Naisbitt DJ, Park BK,. Role of bioactivation in drug-induced hypersensitivity reactions. AAPS J 2006; 8: E55-E64. (Pubitemid 44603864)
17. Obermayer-Straub P, Strassburg CP, Manns MP,. Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases. Can J Gastroenterol 2000; 14: 429-439. (Pubitemid 30339370)
18. Mizutani T, Shinoda M, Tanaka Y, et al. Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2. Drug Metab Rev 2005; 37: 235-252. (Pubitemid 40250290)
19. Eliasson E, Gardner I, Hume-Smith H, et al. Interindividual variability in P450-dependent generation of neoantigens in halothane hepatitis. Chem Biol Interact 1998; 116: 123-141. (Pubitemid 29023158)
20. Owen AD, van der Veen BW,. Perspectives in the pathogenesis of halothane-induced hepatitis. S Afr Med J 1986; 69: 807-810. (Pubitemid 16066684)
21. Rivera Penera T, Gugig R, Davis J, et al. Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity [see comments]. J Pediatr 1997; 130: 300-304. (Pubitemid 27495169)
22. Kearns GL, Leeder JS, Wasserman GS,. Acetaminophen overdose with therapeutic intent. J Pediatr 1998; 132: 5-8. (Pubitemid 28082523)
23. Slattery JT, Nelson SD, Thummel KE,. The complex interaction between ethanol and acetaminophen. Clin Pharmacol Ther 1996; 60: 241-246. (Pubitemid 26354444)
24. Manyike PT, Kharasch ED, Kalhorn TF, et al. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clin Pharmacol Ther 2000; 67: 275-282. (Pubitemid 30176386)
25. American Academy of Pediatrics: Committee on Drugs. Acetaminophen toxicity in children. Pediatrics 2001; 108: 1020-1024.
26. Donato MT, Serralta A, Jimenez N, et al. Liver grafts preserved in Celsior solution as source of hepatocytes for drug metabolism studies: comparison with surgical liver biopsies. Drug Metab Dispos 2005; 33: 108-114. (Pubitemid 40023521)
27. Turpeinen M, Tolonen A, Chesne C, et al. Functional expression, inhibition and induction of CYP enzymes in HepaRG cells. Toxicol In Vitro 2009; 23: 748-753.
28. Madan A, Graham RA, Carroll KM, et al. Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab Dispos 2003; 31: 421-431. (Pubitemid 36378519)
29. Herd DW, Anderson BJ, Keene NA, et al. Investigating the pharmacodynamics of ketamine in children. Paediatr Anaesth 2008; 18: 36-42. (Pubitemid 350264604)
30. Schuttler J, Stanski DR, White PF, et al. Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man. J Pharmacokinet Biopharm 1987; 15: 241-253. (Pubitemid 18043939)
31. Audenaert SM, Montgomery CL, Thompson DE, et al. A prospective study of rectal methohexital: efficacy and side effects in 648 cases. Anesth Analg 1995; 81: 957-961.